POINT-OF-CARE HEMATOLOGY
HemoScreen™
CE-marked portable complete blood count analyser — lab-quality results in 5 minutes from a single drop of blood. For medical practice, emergency, oncology, intensive care and the pre-hospital environment.
Model: PixCell HemoScreen
THE TECHNOLOGY
AI-assisted Viscoelastic Focusing (VEF)
VEF is a novel physical phenomenon — protected by over 20 patents — that aligns cells into a single layer, perfect for optical analysis. Unlike hydrodynamic focusing, it needs no diluent and is not sensitive to clogging or vibration. This is the key to miniaturising flow cytometry.
- Lab-on-a-cartridge: all reagents included, factory-calibrated
- No maintenance, no daily calibration
- AI & machine vision — real-time cell classification
- No cross-contamination (sealed cartridges)
HOW IT WORKS
3 simple steps, accessible to anyone
-
1
Collect the sample
A single drop — capillary (finger) or venous.
-
2
Insert into the cartridge
Sealed cartridge, with all reagents included.
-
3
Read the result
20 parameters, 5-part diff, in 5 minutes.
CLINICAL EVIDENCE
Published peer-reviewed studies
HemoScreen is backed by independent research in recognised international journals.
BMJ Journal of Clinical Pathology
A Novel Haematology Analyser for the Point of Care
The Journal of Applied Laboratory Medicine
A Novel Approach to Haematology Testing at the Point of Care
eJHaem
HemoScreen vs Sysmex XN — CBC, WBC differential and abnormal leukocytes
International Journal of Laboratory Haematology
Rapid assessment of acute leukaemia patients with HemoScreen
BMC Family Practice
Rapid red-cell parameter testing in primary care
The Journal of Applied Laboratory Medicine
Three POC CBC analysers for monitoring clozapine therapy
Journal of Psychiatric Research
POC haematology for clozapine monitoring (SLAM NHS Trust)
CLINICAL EVALUATIONS
What the experts say
Simple to operate, extremely portable and reliable. Non-technical staff learned testing quickly. Useful for acute leukaemia, severe neutropenia and platelet disorders.
Verified performance and usability: extremely easy to use, very accurate — suitable for emergency and primary care.
HemoScreen solves a real unmet need in the oncology clinic — immediate CBC results for chemotherapy patients.
Time to result was 20 minutes shorter vs the clinical laboratory. Cost-effective for emergency clinics.
A robust analytical method with a single-use cartridge and easy operation — HemoScreen is a good choice for small outpatient clinics.
CLINICAL APPLICATION
Changing Cancer Care — home testing
As part of the Interreg Germany-Denmark initiative, oncology patients in Denmark were trained to use HemoScreen for the 5-part CBC test required in treatment management — reducing immunocompromised patients' exposure to infection in hospital.
HemoScreen is not approved for home use. The collaboration was conducted under local ethical approval.
Want HemoScreen in your clinic/hospital?
The Hellimed team offers technical consulting, demo, configuration and service.
Request a quote for HemoScreen